- US-listed companies
- IMMUNIC, INC.
- Cash flow
IMMUNIC, INC. (IMUX) Cash flow
Market cap
$1.3B
P/E ratio
| 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Depreciation & amortization | 1 | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based compensation | 3 | 4 | 5 | 5 | 4 | 7 | 3 | 6 | 8 | 7 | 9 | 9 |
| Cash from operations | -41 | -50 | -36 | -40 | -43 | -29 | -46 | -83 | -65 | -71 | -85 | -86 |
| Capital expenditures | -1 | -2 | -1 | -1 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Cash from investing | -2 | -1 | -0 | -1 | -0 | 11 | -0 | -0 | -10 | 9 | -0 | -0 |
| Cash from financing | 107 | 32 | 12 | 38 | 0 | 35 | 144 | 43 | 96 | 1 | 75 | 66 |
| Free cash flow |